Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furst

Showing results (141-150 of 1,662) with videos related to

Pageof 167
Sort By:
Drug News & Perspectives|May 11, 2005
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnessesLaszlo Köles, Susanna Furst, Peter Illes
Clinics in Geriatric Medicine|May 25, 2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Arthritis Research & Therapy|August 29, 2014
Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacyThasia G Woodworth, Daniel E Furst
Rheumatic Diseases Clinics of North America|July 27, 2015
Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic ApproachesElizabeth R Volkmann, Daniel E Furst
Expert Review of Clinical Immunology|July 11, 2017
Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic reviewAly M Aly, Daniel E Furst
Arzneimittel-Forschung|April 1, 1988
Analgesic profile of rimazolium as compared to different classes of pain killersS Furst, K Gyires, J Knoll
Rheumatic Diseases Clinics of North America|November 15, 1997
Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and designJ L Hillson, D E Furst
Chemistry & Biology|June 30, 2015
DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal TumorsAriel L Furst, Jacqueline K Barton
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|December 22, 2006
Comparison of structure, strength and cytocompatibility of a fibrin matrix supplemented either with tranexamic acid or aprotininWalter Furst, Asmita Banerjee, Heinz Redl
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Problems encountered during anti-tumour necrosis factor therapySheetal B Desai, Daniel E Furst
Pageof 167

Showing results (141-150 of 1,662) with videos related to

Sort By:
Pageof 167
Drug News & Perspectives|May 11, 2005
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnessesLaszlo Köles, Susanna Furst, Peter Illes
Clinics in Geriatric Medicine|May 25, 2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Arthritis Research & Therapy|August 29, 2014
Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacyThasia G Woodworth, Daniel E Furst
Rheumatic Diseases Clinics of North America|July 27, 2015
Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic ApproachesElizabeth R Volkmann, Daniel E Furst
Expert Review of Clinical Immunology|July 11, 2017
Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic reviewAly M Aly, Daniel E Furst
Arzneimittel-Forschung|April 1, 1988
Analgesic profile of rimazolium as compared to different classes of pain killersS Furst, K Gyires, J Knoll
Rheumatic Diseases Clinics of North America|November 15, 1997
Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and designJ L Hillson, D E Furst
Chemistry & Biology|June 30, 2015
DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal TumorsAriel L Furst, Jacqueline K Barton
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|December 22, 2006
Comparison of structure, strength and cytocompatibility of a fibrin matrix supplemented either with tranexamic acid or aprotininWalter Furst, Asmita Banerjee, Heinz Redl
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Problems encountered during anti-tumour necrosis factor therapySheetal B Desai, Daniel E Furst
Pageof 167